Alamar Biosciences, Inc.
NASDAQ:ALMR · NASDAQ Global Select
+$1.11 today
Vol 0.69M · Avg 0.38M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
18.8%
avg 18.8%
ROIC
-26.5%
avg -26.5%
ROA
-21.3%
avg -21.3%
Analysis
ROE is currently the strongest return metric at 18.8% versus its period average of 18.8%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Yuling Luo | Co-Founder, Chairman & CEO | $662,065.00 | — | 62 | $1.94M | 20.70% |
Shiping Chen | Co-Founder, COO & Director | $543,055.00 | — | 63 | $12,190.00 | 0.13% |
Justin J. McAnear | Chief Financial Officer | $235,849.00 | — | 50 | $570,719.00 | 6.09% |
Stephen A. Williams | Chief Scientific Officer | — | — | 66 | — | — |
Xiao-Jun Ma | Chief Technology Officer | — | — | — | — | — |
Alex Forrest-Hay | Senior Vice President of Sales | — | — | — | — | — |
Micah Litow | Senior VP of AI & Strategic Initiatives | — | — | — | — | — |
Timothy O. White | President | — | — | 58 | $454,583.00 | 4.85% |
Anna Berdine | Senior Vice President of Marketing | — | — | — | — | — |
Yiyuan Yin | Founder, VP of Technology & Acting Secretary | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$8.00M
Sells
0
$0.00
Net Sentiment
+$8.00M
Net buying
Most Active
Illumina Innovation Fund II GP, L.L.C.
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. Indirect | Buy | 235.3K | $17.00 | $3,999,998.00 | |
| Apr 20, 2026 | Naclerio Nicholas Indirect | Buy | 235.3K | $17.00 | $3,999,998.00 |
Analysis
Insiders reported 2 buys worth $8.00M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $8.00M. Illumina Innovation Fund II GP, L.L.C. was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +41.8% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +41.8% (5yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
No competitor data available.
Who manages ALMR?
Alamar Biosciences, Inc. (ALMR) lists 10 active executives. The top listed executive is Shiping Chen, Co-Founder, COO & Director.
Are ALMR insiders buying or selling?
Recent insider activity shows net buying of $27.54M.
Explore More
Continue the stock analysis
Jump to another research area for this company.